Microfluidic-Generated Injectable Bulking Agents with Biocompatible Surfaces and Their Mid-term Outcomes in a Rat Model with Anal Sphincter Injury.

ACS Omega · 2024 · PMC11525505 · PMID 39494012

Europe PMC DOI

hedged sentence

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

borderline significancep = 0.081so close (0.05 < p ≤ 0.1)

The findings exhibited borderline significance (ZcPH-MF, 6.07 ± 1.58 vs UcPH-MF, 4.79 ± 2.19, p = 0.081).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.